{"SLR NAME":"Olfactory and gustatory dysfunctions in COVID-19 patients: a systematic review and meta-analysis","References":[{"title1":"Self?reported olfactory loss associates with outpatient clinical course in COVID?19","References":[{"title2":"Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations","References":[{"title3":"Escaping Pandora's box:another novel coronavirus"},{"title3":"COVID-19 coronavirus pandemic"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Critical care crisis and some recommendations during the COVID-19 epidemic in China"},{"title3":"Intensive care during the coronavirus epidemic"},{"title3":"Real estimates of mortality following COVID-19 infection"},{"title3":"Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)"},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response"},{"title3":"COVID-19 and Italy: what next?"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state"},{"title3":"Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias"},{"title3":"Global surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance"},{"title3":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"SARS in a hospital visitor and her intensivist"},{"title3":"Expert consensus for bronchoscopy during the epidemic of 2019 novel coronavirus infection (Trial version)"},{"title3":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore"},{"title3":"Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): a systematic review"},{"title3":"Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)"},{"title3":"Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review"},{"title3":"Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections"},{"title3":"Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks"},{"title3":"Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial"},{"title3":"Noninvasive ventilation in acute hypoxemic nonhypercapnic respiratory failure: a systematic review and meta-analysis"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis"},{"title3":"Failure of high-flow nasal cannula therapy may delay intubation and increase mortality"},{"title3":"Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients"},{"title3":"An official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine clinical practice guideline: Mechanical ventilation in adult patients with acute respiratory distress syndrome"},{"title3":"Treatment for severe acute respiratory distress syndrome from COVID-19"},{"title3":"Assessment of therapeutic interventions and lung protective ventilation in patients with moderate to severe acute respiratory distress syndrome: a systematic review and network meta-analysis"},{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus"},{"title3":"Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases"},{"title3":"Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target"},{"title3":"COVID-19 and the cardiovascular system"},{"title3":"Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis"},{"title3":"Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis"},{"title3":"Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients"},{"title3":"Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients"},{"title3":"The clinical characteristics of pneumonia patients co-infected with 2019 novel coronavirus and influenza virus in Wuhan, China"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Corticosteroid therapy for critically ill patients with Middle East Respiratory Syndrome"},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza"},{"title3":"Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance"},{"title3":"Safe patient transport for COVID-19"},{"title3":"Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units:the experience in Sichuan Province, China"},{"title3":"Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic"},{"title3":"Viral dynamics in mild and severe cases of COVID-19"},{"title3":"Informal consultation on prioritization of candidate therapeutic agents for use in novel coronavirus 2019 infection"},{"title3":"A randomized, controlled trial of Ebola virus disease therapeutics"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19"},{"title3":"Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-beta1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial"},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies"},{"title3":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Treating COVID-19-Off-label drug use, compassionate use, and randomized clinical trials during pandemics"},{"title3":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial"},{"title3":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"},{"title3":"Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study"},{"title3":"Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo"},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis"},{"title3":"Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol"},{"title3":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma"},{"title3":"Advances in the research of cytokine storm mechanism induced by corona virus disease 2019 and the corresponding immunotherapies"},{"title3":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)"},{"title3":"COVID-19: An update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese-Western medicine for the management of 2019 novel coronavirus disease"},{"title3":"XueBiJing injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial"},{"title3":"Ethical considerations for use of unregistered interventions for Ebola viral disease: report of an advisory panel to WHO"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19): interim guidance"},{"title3":"Expanding ICU facilities in an epidemic: recommendations based on experience from the SARS epidemic in Hong Kong and Singapore"},{"title3":"COVID-19 in Singapore-current experience: critical global issues that require attention and action"},{"title3":"Strategies for optimizing the supply of n95 respirators: crisis/alternate strategies"},{"title3":"Performance of a novel non-fit-tested HEPA filtering face mask"},{"title3":"Contamination: a comparison of 2 personal protective systems"},{"title3":"Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists"},{"title3":"Transmission of SARS to healthcare workers. The experience of a Hong Kong ICU"},{"title3":"Contamination of healthcare workers' mobile phones by epidemic viruses"},{"title3":"Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient"},{"title3":"Extensive viable Middle East respiratory syndrome (MERS) coronavirus contamination in air and surrounding environment in MERS isolation wards"},{"title3":"Interim infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease 2019 (COVID-19) in healthcare settings"},{"title3":"Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"Structure, organization, and delivery of critical care in Asian ICUs"},{"title3":"A controlled crossover human volunteer study of the in vivo filtration efficacy of a high-efficiency particulate air-filtering oxygen mask"},{"title3":"The global community needs to swiftly ramp up the response to contain COVID-19"},{"title3":"Critical care bed capacity in Asian countries and regions"},{"title3":"The variability of critical care bed numbers in Europe"},{"title3":"Facing Covid-19 in Italy:ethics, logistics, and therapeutics on the epidemic's front line"},{"title3":"Intensive care unit capacity in low-income countries: a systematic review"},{"title3":"Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study"},{"title3":"Surge capacity logistics: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement"},{"title3":"Are high nurse workload/staffing ratios associated with decreased survival in critically ill patients? A cohort study"},{"title3":"A systematic review of short courses for nonspecialist education in intensive care"},{"title3":"Preparing for COVID-19: early experience from an intensive care unit in Singapore"},{"title3":"Supporting the health care workforce during the COVID-19 global epidemic"},{"title3":"Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed"},{"title3":"The psychological impact of the SARS epidemic on hospital employees in China: exposure, risk perception, and altruistic acceptance of risk"},{"title3":"Triage: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement"},{"title3":"Clinical ethics recommendations for the allocation of intensive care treatments, in exceptional, resource-limited circumstances"},{"title3":"COVID-19 rapid guideline: critical care"},{"title3":"Effect of intravenous interferon beta-1a on death and days free from mechanical ventilation among patients with moderate to severe acute respiratory distress syndrome: a randomized clinical trial"},{"title3":"InFACT: a global critical care research response to H1N1"},{"title3":"A multi-centre, adaptive, randomized, double-blind, placebo-controlled clinical trial of the safety and efficacy of investigational therapeutics for the treatment of COVID-19 in hospitalized patients"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Preprints: an underutilized mechanism to accelerate outbreak science"},{"title3":"Reporting quality of the 2014 Ebola outbreak in Africa: a systematic analysis"}]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"Clinical characteristics of patients who died of coronavirus disease 2019 in China","References":[{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":" Bulletin of the National Health Commission of the People's Republic of China on the 2019 new coronavirus infection. Accessed March 8, 2020. http://www.nhc.gov.cn/xcs/xxgzbd/gzbd_index.shtml"},{"title3":" Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Accessed March 8, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected"},{"title3":"Noninvasive ventilation for acute respiratory failure"},{"title3":"The epidemiology of sepsis in Chinese ICUs: a national cross-sectional survey"}]},{"title2":"Covid-19 in critically ill patients in the Seattle region:case series","References":[{"title3":"Novel coronavirus : China"},{"title3":"Coronavirus COVID-19 global cases"},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"2019 Novel coronavirus outbreak (COVID-19)"},{"title3":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State."},{"title3":"Priorities for the US health community responding to COVID-19."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Coronavirus disease 2019 (COVID-19)"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome."},{"title3":"Prone positioning in severe acute respiratory distress syndrome."},{"title3":"Bacterial coinfection in influenza: a grand rounds review."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients."},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis."},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China."},{"title3":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care."},{"title3":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement."}]},{"title2":"Universal screening for SARS-CoV-2 in women admitted for delivery","References":[]},{"title2":"Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study","References":[{"title3":"A review of studies on animal reservoirs of the SARS coronavirus"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility"},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis"},{"title3":"Coronavirus disease 2019 (COVID-19): situation report:41"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"The remaining challenge of pneumonia: the leading killer of children"},{"title3":"Child pneumonia at a time of epidemiological transition"},{"title3":"Severe acute respiratory syndrome among children"},{"title3":"Middle East respiratory syndrome coronavirus disease is rare in children: an update from Saudi Arabia"},{"title3":"Analysis of CT features of 15 children with 2019 novel coronavirus infection"},{"title3":"Diagnosis and treatment guidelines for 2019 novel coronavirus pneumonia (draft version 5)"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Novel primers and probes for detection of novel coronavirus 2019"},{"title3":"Diagnosis and treatment recommendation for pediatric coronavirus disease-19"},{"title3":"Hypokalemia and clinical implications in patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Severe acute respiratory syndrome (SARS): chest radiographic features in children"},{"title3":"Clinical features of 167 children with the novel influenza A (H1N1) virus infection in Xi'an, China"},{"title3":"An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov)"},{"title3":"Pneumonia: the leading killer of children"},{"title3":"Biomarkers for pediatric sepsis and septic shock"},{"title3":"Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Critical care crisis and some recommendations during the COVID-19 epidemic in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan"},{"title3":"Bulletin of the National Health Commission of China on the 2019 new coronavirus infection. http://www.nhc.gov.cn/xcs/xxgzbd/gzbd_index.shtml. Accessed 11 Feb 2020"},{"title3":"A survey of the development of critical medicine in Hubei Province"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"First Case of 2019 novel cornavirus in the united states"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (2019-nCoV) infection is suspected: Interim Guidance"}]},{"title2":"Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms","References":[{"title3":"Presumed asymptomatic carrier transmission of COVID-19"},{"title3":"Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak"},{"title3":"Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study"},{"title3":"Identification of viruses in patients with postviral olfactory dysfunction"},{"title3":"Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms"},{"title3":"Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients"},{"title3":"Anosmia:a clinical review"}]},{"title2":"Real-time tracking of self-reported symptoms to predict potential COVID-19","References":[{"title3":"Coronavirus: rolling out community testing for COVID-19 in the NHS"},{"title3":"A framework for identifying regional outbreak and spread of COVID-19 from one-minute population-wide surveys"},{"title3":"Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome?"},{"title3":"Sixty seconds on... anosmia"},{"title3":"Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia"},{"title3":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes"},{"title3":"Sudden and complete olfactory loss function as a possible symptom of COVID-19"},{"title3":"Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection"},{"title3":"Rapid implementation of mobile technology for real-time epidemiology of COVID-19"},{"title3":"Coronavirus: are loss of smell and taste key symptoms?"},{"title3":"Consequences of undetected olfactory loss for human chemosensory communication and well-being"},{"title3":"Computationally efficient confidence intervals for cross-validated area under the ROC curve estimates"}]},{"title2":"Smell dysfunction: a biomarker for COVID-19","References":[{"title3":"Sudden and complete olfactory loss function as a possible symptom of COVID-19"},{"title3":"[The Covid-19 pandemic and otolaryngology: what it comes down to?]"},{"title3":"Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection"},{"title3":"Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak"},{"title3":"Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study"},{"title3":"Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms"},{"title3":"Unawareness of olfactory dysfunction and its association with cognitive functioning in middle aged and old adults"},{"title3":"Accuracy of self-report in detecting taste dysfunction"},{"title3":"Presence of both odor identification and detection deficits in Alzheimer's disease"},{"title3":"Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"},{"title3":"A fourteen-day experience with coronavirus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS): an Iranian treatment protocol"},{"title3":"Smell identification ability: changes with age"},{"title3":"Internal consistency reliability of the fractionated and whole university of Pennsylvania smell identification test"},{"title3":"Clinical validation of the olfactory detection threshold module of the Snap &amp; Sniff(R) olfactory test system"},{"title3":"Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration"},{"title3":"Odor identification deficit of the parkinsonism-dementia complex of Guam: equivalence to that of Alzheimer's and idiopathic Parkinson's disease"},{"title3":"Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis"},{"title3":"The olfactory vector hypothesis of neurodegenerative disease: is it viable?"},{"title3":"Olfactory dysfunction from acute upper respiratory infections: relationship to season of onset"},{"title3":"Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses"},{"title3":"Non-neural expression of SARS-ClV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVD-19 patients"},{"title3":"SARS-CoV-2: olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection"},{"title3":"The balance between efficient anti-inflammatory treatment and neuronal regeneration in the olfactory epithelium"},{"title3":"Olfactory epithelium: cells, clinical disorders, and insights from an adult stem cell niche"},{"title3":"Primary cilia on horizontal basal cells regulate regeneration of the olfactory epithelium"},{"title3":"Predictors of prognosis in patients with olfactory disturbance"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, February 12-March 28, 2020"},{"title3":"ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19"},{"title3":"Olfactory function in chemical workers exposed to acrylate and methacrylate vapors"},{"title3":"Olfactory dysfunction in Parkinson's disease: positive effect of cigarette smoking"},{"title3":"Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center"},{"title3":"The effects of mouth movements, swallowing, and spitting on retronasal odor perception"},{"title3":"[Analysis of clinical characteristics of 141 patients with postviral olfactory dysfunction]"},{"title3":"Influence of medications on taste and smell"},{"title3":"False-negative results of real-time reverse-transcriptase polymerase chain reaction for severe acute respiratory syndrome coronavirus 2: role of deep-learning-based CT diagnosis and insights from two cases"},{"title3":"Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China"},{"title3":"Prevalence and clinical features of 2019 novel coronavirus disease (COVID-19) in the Fever Clinic of a teaching hospital in Beijing: a single-center, retrospective study"},{"title3":"Herpes viruses and Alzheimer's disease: new evidence in the debate"},{"title3":"Viral mimetic priming enhances alpha-synuclein-induced degeneration: implications for Parkinson's disease"},{"title3":"Olfactory dysfunction predicts 5-year mortality in older adults"},{"title3":"Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community"}]},{"title2":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study","References":[{"title3":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study"},{"title3":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China"},{"title3":"Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study"}]},{"title2":"The use of google trends to investigate the loss of smell related searches during COVID-19 outbreak","References":[{"title3":"Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China"},{"title3":"  . https://www.nhs.uk/conditions/coronavirus-covid-19/symptoms-and-what-to-do/. Accessed March 25, 2020."},{"title3":"Google Trends: a web-based tool for real-time surveillance of disease outbreaks"},{"title3":"Google Trends terms reporting rhinitis and related topics differ in European countries"},{"title3":"COVID19 information for the public"},{"title3":"  . https://www.mscbs.gob.es/en/home.htm. Accessed March 25, 2020."},{"title3":"  . http://www.protezionecivile.it/. Accessed March 25, 2020."},{"title3":"Loss of sense of smell as marker of COVID'19 infection [press release]"},{"title3":"COCOR: a comprehensive solution for the statistical comparison of correlations"},{"title3":"Treatment approach announced for pandemic flu"},{"title3":"  . https://en.wikipedia.org/wiki/2009_flu_pandemic_in_the_United_Kingdom#cite_note-HPAtreatmentApproach-34. Accessed March 25, 2020."},{"title3":"An epidemiological study of postviral olfactory disorder"},{"title3":"Post-infectious olfactory dysfunction exhibits a seasonal pattern"},{"title3":"A data science-based analysis of seasonal patterns in outpatient presentations due to olfactory dysfunction"},{"title3":"Assessment of thunderstorm-induced asthma using Google Trends"},{"title3":"Loss of sense of smell among Iranians coinciding with coronavirus epidemic"},{"title3":"AAO-HNS: Anosmia, Hyposmia, and Dysgeusia Symptoms of Coronavirus Disease"}]},{"title2":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","References":[]},{"title2":"Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study","References":[]},{"title2":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis","References":[]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Unawareness of olfactory dysfunction and its association with cognitive functioning in middle aged and old adults","References":[]},{"title2":"Apgar score and the risk of cause-specific infant mortality: a population-based cohort study","References":[]},{"title2":"Experimental infection of human volunteers","References":[]},{"title2":"Sudden and complete olfactory loss function as a possible symptom of COVID-19","References":[]},{"title2":"Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients","References":[]},{"title2":"The molecular basis of loss of smell in 2019-NCoV infected individuals","References":[]},{"title2":"Anosmia:a clinical review","References":[]}]},{"title1":"Acute?onset smell and taste disorders in the context of COVID?19: a pilot multicentre polymerase chain reaction based case–control study","References":[{"title2":"Epidemiology of smell and taste dysfunction","References":[]},{"title2":"Treatment for smell and taste disorders: a critical review","References":[]},{"title2":"Postviral olfactory loss","References":[{"title3":"Characteristics of olfactory disorders in relation to major causes of olfactory loss"},{"title3":"Identification of viruses in patients with postviral olfactory dysfunction"},{"title3":"Prevalence of olfactory dysfunction in coronavirus disease 2019 (COVID-19): A meta-analysis of 27,492 patients"},{"title3":"Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: A study of 2579 patients"},{"title3":"Psychophysical evaluation of the olfactory function: European multicenter study on 774 COVID-19 patients"},{"title3":"Objective evaluation of anosmia and ageusia in COVID-19 patients: Single center experience on 72 cases"},{"title3":"Prevalence of olfactory dysfunction in D614G, alpha, delta and omicron waves: A psychophysical case-control study"},{"title3":"Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variant"},{"title3":"Smell and taste dysfunction after COVID-19"},{"title3":"COVID-19 related persistent olfactory disorders represent an unprecedented challenge"},{"title3":"Prognosis and persistence of smell and taste dysfunction in patients with COVID-19: Meta-analysis with parametric cure modelling of recovery curves"},{"title3":"Chemosensory dysfunctions induced by COVID-19 can persist up to 7 months: A study of over 700 healthcare workers"},{"title3":"Six-month psychophysical evaluation of olfactory dysfunction in patients with COVID-19"},{"title3":"The importance of the olfactory system in human well-being, through nutrition and social behavior"},{"title3":"Impact of olfactory dysfunction on quality of life in coronavirus disease 2019 patients: A systematic review"},{"title3":"Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study"},{"title3":"New onset of smell and taste loss are common findings also in patients with symptomatic COVID-19 after complete vaccination"},{"title3":"Smell Dysfunction: A biomarker for COVID-19"},{"title3":"Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms"},{"title3":"Is loss of sense of smell a diagnostic marker in COVID-19: A systematic review and meta-analysis"},{"title3":"Self-reported olfactory loss associates with outpatient clinical course in COVID-19"},{"title3":"Self-reported olfactory loss in COVID-19: Is it really a favorable prognostic factor?"},{"title3":"Do olfactory and gustatory psychophysiocal scores have prognostic value in COVID-19 patients? A prospective study of 106 patients"},{"title3":"Long-term follow-up of olfactory and gustatory dysfunction in COVID-19: 6 months case-control study in health workers"},{"title3":"Six-month smell and taste recovery rates in coronavirus disease 2019 patients: A prospective psychophysical study"},{"title3":"Six month follow-up of self-reported loss of smell during the COVID-19 pandemic"},{"title3":"Prevalence of persistent olfactory disorders in patients with COVID-19: A psychophysical case-control study with 1-year follow-up"},{"title3":"Self-reported smell and taste recovery in coronavirus disease 2019 patients: A one-year prospective study"},{"title3":"High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: A matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation"},{"title3":"Prevalence and 24-month recovery of olfactory dysfunction in COVID-19 patients: A multicentre prospective study"},{"title3":"Two-year prevalence and recovery rate of altered sense of smell and taste in patients with mildly symptomatic COVID-19"},{"title3":"Parosmia assessment with structured questions and its functional impact in patients with long-term COVID-19-related olfactory dysfunction"},{"title3":"Correlations between olfactory psychophysical scores and SARS-CoV-2 viral load in COVID-19 patients"},{"title3":"Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: Is there any correlation?"},{"title3":"Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: A preliminary study"},{"title3":"Analysis of the correlations between the severity of lung involvement and olfactory and psychophysical scores in coronavirus disease 2019 (COVID-19) patients"},{"title3":"Smell and taste alterations in COVID-19: A cross-sectional analysis of different cohorts"},{"title3":"Olfactory dysfunction and sinonasal symptomatology in COVID-10: Prevalence, severity, timing, and associated characteristics"},{"title3":"Prevalence of anosmia and ageusia in patients with COVID-19 at a primary heart center, Doha, Qatar"},{"title3":"Objective olfactory findings in hospitalized severe COVID-19 patients"},{"title3":"Mood, anxiety and olfactory dysfunction in COVID-19: Evidence of central nervous system involvement?"},{"title3":"Olfactory and oral manifestations of COVID-19: Sex-related symptoms:A potential pathway to early diagnosis"},{"title3":"Study of clinical and biological characteristics of Maroccan COVID-19 patients with and without olfactory and/or gustatory dysfunction"},{"title3":"Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction"},{"title3":"The role of nasal immunoglobulins in the recovery of olfactory function in COVID-19 patients"},{"title3":"Potential pathogenesis of ageusia and anosmia in COVID-19 patients"},{"title3":"COVID-19 anosmia: High prevalence, plural neuropathogenic mechanisms, and scarce neurotropism of SARS-CoV-2?"},{"title3":"Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia"},{"title3":"COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters"},{"title3":"Clinical and radiological evaluations of COVID-19 patients with anosmia: Preliminary report"},{"title3":"ACE2 &amp; TMPRSS2 expressions in head &amp; neck tissues: A systemic review"},{"title3":"Management of new onset loss of sense of smell during the COVID-19 pandemic-BRS consensus guidelines"},{"title3":"Efficacy of corticosteroid therapy in the treatment of long-lasting olfactory disorders in COVID-19 patients"},{"title3":"Olfactory dysfunction in COVID-19: Diagnosis and management"},{"title3":"Specific therapy of olfactory disorders in COVID-19 patients is essential for the prevention of long-term dysfunction"},{"title3":"Short-term efficacy and safety of oral and nasal corticosteroids in COVID-19 patients with olfactory dysfunction: A European multicenter study"},{"title3":"The interest of fluticasone nasal spray in COVID-19 related anosmia is still not demonstrated"},{"title3":"Effectiveness of olfactory training in COVID-19 patients with olfactory dysfunction: A prospective study"},{"title3":"SARS-CoV-2 leads to significantly more severe olfactory loss than other seasonal cold viruses"},{"title3":"SARS-CoV-2 infection and taste alteration: An overview"},{"title3":"Exploring the clinical utility of gustatory dysfunction (GD) as a triage symptom prior to reverse transcription polymerase chain reaction (RT-PCR) in the diagnosis of COVID-19: A meta-analysis and systematic review"},{"title3":"Unmasking the &quot;asymptomatic&quot; COVID-19: A nose question"},{"title3":"COVID-19 smell impairment and crasstalk with hypoxia physiology"},{"title3":"Anosmia testing as early detection of SARS-CoV-2 positivity; a prospective study under screening conditions"},{"title3":"Two-year follow-up on chemosensory dysfunction and adaptive immune response after infection with SARS-CoV-2 in a cohort of 44 healthcare workers"},{"title3":"Chemosensory dysfunction in long-term COVID-19 assessed by self-reported and direct psychophysical methods"},{"title3":"The effects of persistent olfactory and gustatory dysfunctions on quality of life in long-COVID-19 patients"},{"title3":"Analysis of prevalence and predictive factors of long-lasting olfactory and gustatory dysfunction in COVID-19 patients"},{"title3":"Asthma and cacosmia could be predictive factors of olfactory dysfunction persistence 9 months after SARS-CoV-2 infection: The ANOSVID study"},{"title3":"Topical administration of mometasone is no helpful in post-COVID-19 olfactory dysfunction"},{"title3":"Gustatory and saliva secretory dysfunctions in COVID-19 patients with zinc deficiency"},{"title3":"COVID-19 and the chemical senses: Supporting players take center stage"}]},{"title2":"Identification of viruses in patients with postviral olfactory dysfunction","References":[{"title3":"Hypogeusia, dysgeusia, hyposmia, and dysosmia following influenza-like infection"},{"title3":"Olfactory dysfunctions. Epidemiology and therapy in Germany, Austria and Switzerland"},{"title3":"The diagnosis of a conductive olfactory loss"},{"title3":"Patterns of non-conductive olfactory disorders in eastern Austria: a study of 120 patients from the Department of Otorhinolaryngology at the University of Vienna"},{"title3":"Clinical features of olfactory disorders in patients seeking medical consultation"},{"title3":"Anosmia and ageusia: common findings in COVID-19 patients"},{"title3":"Olfactory disorders following upper respiratory tract infections"},{"title3":"Identification of viruses in patients with postviral olfactory dysfunction"},{"title3":"Detection of parainfluenza virus 3 in turbinate epithelial cells of postviral olfactory dysfunction patients"},{"title3":"Post-infectious olfactory dysfunction exhibits a seasonal pattern"},{"title3":"An epidemiological study of postviral olfactory disorder"},{"title3":"Sniffin' Sticks: a new olfactory test battery"},{"title3":"&quot;Sniffin' sticks&quot;: screening of olfactory performance"},{"title3":"Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold"},{"title3":"Normative data for the &quot;Sniffin' sticks&quot; including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects"},{"title3":"Human rhinovirus 87 identified as human enterovirus 68 by VP4-based molecular diagnosis"},{"title3":"Detection and differentiation of picornaviruses in clinical samples following genomic amplification"},{"title3":"Parainfluenza virus type 1 infects olfactory neurons and establishes long-term persistence in the nerve tissue"},{"title3":"Sendai virus infection in the mouse brain: virus spread and long-term effects"},{"title3":"Human rhinoviruses: the cold wars resume"},{"title3":"Modulation of the immune system by human rhinoviruses"},{"title3":"Rhinoviruses in the pathogenesis of asthma: the bronchial epithelium as a major disease target"},{"title3":"Invasion and persistence of the neuroadapted influenza virus A/WSN/33 in the mouse olfactory system"},{"title3":"Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein"},{"title3":"Detection of the human coronavirus 229E, HKU1, NL63, and OC43 between 2010 and 2013 in Yamagata, Japan"},{"title3":"Middle East respiratory syndrome"},{"title3":"Olfactory threshold and nasal mucosal changes in experimentally induced common cold"},{"title3":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2"},{"title3":"Spread of a neurotropic coronavirus to spinal cord white matter via neurons and astrocytes"},{"title3":"The murine coronavirus as a model of trafficking and assembly of viral proteins in neural tissue"},{"title3":"Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus"},{"title3":"Comparison of three multiplex PCR assays for the detection of respiratory viral infections: evaluation of xTAG respiratory virus panel fast assay, RespiFinder 19 assay and RespiFinder SMART 22 assay"},{"title3":"Laboratory detection of respiratory viruses by automated techniques"},{"title3":"Evaluation of four commercial multiplex molecular tests for the diagnosis of acute respiratory infections"},{"title3":"Comparison of FilmArray respiratory panel and laboratory-developed real-time reverse transcription-polymerase chain reaction assays for respiratory virus detection"},{"title3":"Performance of the Luminex xTAG respiratory viral panel fast in a clinical laboratory setting"},{"title3":"Comparison of the conventional multiplex RT-PCR, real time RT-PCR and Luminex xTAG(R) RVP fast assay for the detection of respiratory viruses"},{"title3":"Comparison of the Luminex respiratory virus panel fast assay with in-house real-time PCR for respiratory viral infection diagnosis"},{"title3":"Comparison of the Luminex xTAG respiratory viral panel with in-house nucleic acid amplification tests for diagnosis of respiratory virus infections"},{"title3":"Performance of a rapid molecular multiplex assay for the detection of influenza and picornaviruses"},{"title3":"Comparison of the Luminex xTAG respiratory viral panel with xTAG respiratory viral panel fast for diagnosis of respiratory virus infections"},{"title3":"Comparison between pernasal flocked swabs and nasopharyngeal aspirates for detection of common respiratory viruses in samples from children"}]},{"title2":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","References":[]},{"title2":"Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study","References":[]},{"title2":"Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak","References":[{"title3":"Position paper on olfactory dysfunction"},{"title3":"Re-establishment of olfactory and taste functions"},{"title3":"Smell and taste disorders"},{"title3":"Biopsies of human olfactory epithelium"},{"title3":" World Health Organization. March 2020. "},{"title3":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)"},{"title3":"Coronavirus disease 2019 (COVID-19): situation report"},{"title3":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak"},{"title3":"COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease"},{"title3":"Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study"},{"title3":"Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak"},{"title3":"Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms"},{"title3":"A primer on viral-associated olfactory loss in the era of COVID-19"},{"title3":"The use of google trends to investigate the loss of smell related searches during COVID-19 outbreak"},{"title3":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study"},{"title3":"Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection"},{"title3":"Smell dysfunction: a biomarker for COVID-19"},{"title3":"COVID-19 Anosmia Reporting Tool: Initial Findings"},{"title3":"Identification of viruses in patients with postviral olfactory dysfunction"},{"title3":"Postviral olfactory loss"},{"title3":"Postviral olfactory loss; in Seiden AM (ed): Taste and Smell Disorders"},{"title3":"Behavioural deficits and serotonin depletion in adult rats after transient infant nasal viral infection"},{"title3":"Effect of olfactory bulb ablation on spread of a neurotropic coronavirus into the mouse brain"},{"title3":"Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms"}]},{"title2":"Early spread of SARS-CoV-2 in the Icelandic population","References":[]},{"title2":"COVID-19 (corona virus) and smell loss - guidance from fifth sense Medical Director, ENT UK and the British Rhinological Society. Fifth sense: smell, taste, life","References":[]},{"title2":"Recomendaciones de la Sociedad Espanola de Neurologia (SEN) en relacion con la perdida de olfato como posible sintoma precoz de infeccion por CoVID-19","References":[]},{"title2":"Investigation of chemosensitivity during and after an acute cold","References":[]}]},{"title1":"Utility of hyposmia and hypogeusia for the diagnosis of COVID-19","References":[{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Loss of sense of smell as marker of COVID-19 infection","References":[]},{"title2":"Gustatory dysfunction after mandibular zoster","References":[]},{"title2":"Taste and smell losses in HIV infected patients","References":[]},{"title2":"The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients","References":[]},{"title2":"Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study","References":[]},{"title2":"Detection of SARS-CoV-2 in different types of clinical specimens","References":[{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov"},{"title3":"Smoking upregulates angiotensin-converting enzyme-2 Receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19)"},{"title3":"Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"Sputum and feces after conversion of pharyngeal samples in patients with COVID-19"},{"title3":"Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multicenter descriptive study"},{"title3":"Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015: elaboration and explanation"},{"title3":"An evidence-based practice guideline for the peer review of electronic search strategies"},{"title3":"PubMed, ScienceDirect, Scopus or Google Scholar:which is the best search engine for an effective literature research in laser medicine?"},{"title3":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of family cluster"},{"title3":"Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau"},{"title3":"Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously Xiong"},{"title3":"Meta-Analyst: software for meta-analysis of binary, continuous, and diagnostic data"},{"title3":"Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors"},{"title3":"Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study"}]}]},{"title1":"Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study","References":[{"title2":"Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China [manuscript published online ahead of print 16 March 2020]","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19):China, 2020","References":[{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"}]},{"title2":"Smell and taste disorders","References":[]},{"title2":"The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system","References":[]},{"title2":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2","References":[]},{"title2":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","References":[{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability"},{"title3":"Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA.https://jamanetwork.com/journals/jama/fullarticle/2761044 (2020)."},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. https://www.nejm.org/doi/full/10.1056/NEJMoa2001017 (2020)."},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Zou, X. et al. The single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection. Front. Med. http://journal.hep.com.cn/fmd/EN/10.1007/s11684-020-0754-0 (2020)."},{"title3":"Zhao, Y. et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. Preprint at https://www.biorxiv.org/content/10.1101/2020.01.26.919985v1 (2020)."},{"title3":"Zhang, H. et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. Preprint at https://www.biorxiv.org/content/10.1101/2020.01.30.927806v1 (2020)."},{"title3":"Chai, X. et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. Preprint at https://www.biorxiv.org/content/10.1101/2020.02.03.931766v1 (2020)."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Emerging coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome-associated coronavirus"},{"title3":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Computational approaches for interpreting scRNA-seq data"},{"title3":"Guan, W.-J. et al. Clinical characteristics of 2019 novel coronavirus infection in China. Preprint at https://www.medrxiv.org/content/10.1101/2020.02.06.20020974v1 (2020)."},{"title3":"Asymptomatic oral human papillomavirus (HPV) infection in women with a histopathologic diagnosis of genital HPV"},{"title3":"Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory"},{"title3":"Associations between proteasomal activator PA28gamma and outcome of oral squamous cell carcinoma: evidence from cohort studies and functional analyses"},{"title3":"RACK1, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67"},{"title3":"Forrest, A. R. et al. A promoter-level mammalian expression atlas. Nature507, 462-470 (2014)."}]},{"title2":"Development of the University of Pennsylvania smell identification test: a standardized microencapsulated test of olfactory function","References":[]}]},{"title1":"Features of anosmia in COVID-19","References":[{"title2":"Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Centre for Disease Control and Prevention","References":[]},{"title2":"Clinical characteristics of 138 hospitalised patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis, 2020 [Internet]. [cited 2020 Mar 22]; Available from: https://academic.oup.com/cid/advancearticle/doi/10.1093/cid/ciaa272/5807944","References":[]},{"title2":"Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D, et al. Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study. Clin Infect Dis, 2020 [Internet]. [cited 2020 Mar 22]; Available from: https://academic.oup.com/cid/advancearticle/doi/10.1093/cid/ciaa199/5766408","References":[]},{"title2":"Clinical characteristics of 2019 novel coronavirus infection in China","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The continuing 2019nCoV epidemic threat of novel coronaviruses to global health  the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (SARS-CoV-2), December 2019 to January 2020"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster [published online ahead of print, 2020 Jan 24]"},{"title3":"The latest situation of new coronavirus pneumonia as of 24:00 on February"},{"title3":"Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (SARS-CoV-2)"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Pathogenicity and transmissibility of SARS-CoV-2-A quick overview and comparison with other emerging viruses"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Notice on issuing a new coronavirus infected pneumonia diagnosis and treatment plan (Trial Version 5)"},{"title3":"Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan"},{"title3":"early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"30 January 2020 pneumonia epidemic situation of C SARS-CoV-2 infection in Hubei province, China-Hubei Provincial Health Committee"},{"title3":"4 February 2020 pneumonia epidemic situation of SARS-CoV-2 infection in Hubei province, China-Hubei Provincial Health Committee"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronaviruspneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Middle East respiratory syndrome"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus"},{"title3":"CT imaging features of 2019 novel coronavirus (SARS-CoV-2)"},{"title3":"Radiology of severe acute respiratory syndrome (SARS): the emerging pathologic-radiologic correlates of an emerging disease"},{"title3":"Thin-section CT 12 months after the diagnosis of severe acute respiratory syndrome in pediatric patients"},{"title3":"Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China"},{"title3":"Detection of Covid-19 in children in early January 2020 in Wuhan, China"},{"title3":"National Health Commission. Notice on issuing a nw coronary virus pneumonia diagnosis and treatment plan (Trial Version 7)"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"COVID-19 and the otolaryngologist - preliminary evidence-based review","References":[{"title3":"COVID-19 and the otolaryngologist: preliminary evidence-based review"},{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"Diagnostic capability of salivary biomarkers in the assessment of head and neck cancer: a systematic review and meta-analysis"},{"title3":"Noninvasive molecular detection of head and neck squamous cell carcinoma: an exploratory analysis"},{"title3":"Saliva is a reliable, non-invasive specimen for SARS-CoV-2 detection"}]},{"title2":"Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome?","References":[]},{"title2":"Anosmia and ageusia: common findings in COVID-19 patients","References":[{"title3":"Anosmia and ageusia: common findings in COVID-19 patients [published online April 1, 2020]"},{"title3":"Objective evaluation of anosmia and ageusia in COVID-19 patients: a single-center experience on 72 cases [published online April 27, 2020]"},{"title3":"Validation of a self-administered olfactory and gustatory test for the remotely evaluation of COVID-19 patients in home quarantine [published online May 1, 2020]"},{"title3":"Potential pathogenesis of ageusia and anosmia in COVID-19 patients [published online April 27, 2020]"},{"title3":"Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia"}]},{"title2":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicentre European study","References":[]},{"title2":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","References":[{"title3":"World Health Organization (WHO). Coronavirus. Geneva: WHO; 2020 [Accessed 21 Jan 2020]. Available from: https://www.who.int/health-topics/coronavirus "},{"title3":"Zhang Y-Z. Novel 2019 coronavirus genome. Virological. [Accessed 21 Jan 2020]. Available from: http://virological.org/t/novel-2019-coronavirus-genome/319 "},{"title3":"de Groot RJ, Baker SC, Baric R, Enjuanes L, Gorbalenya AE, Holmes KV, et al. Family Coronaviridae. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ. Virus taxonomy: classification and nomenclature of viruses: ninth report of the International Committee on Taxonomy of Viruses. London; Waltham: Academic Press; 2012. p. 806-20."},{"title3":"The severe acute respiratory syndrome."},{"title3":"World Health Organization. (WHO. Novel Coronavirus (2019-nCoV). Situation report - 1. Geneva: WHO; 21 Jan 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf "},{"title3":"SARS testing: First past the post."},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Specific detection by real-time reverse-transcription PCR assays of a novel avian influenza A(H7N9) strain associated with human spillover infections in China."},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction."},{"title3":"Coordinated implementation of chikungunya virus reverse transcription-PCR."},{"title3":"Assay optimization for molecular detection of Zika virus."},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences."},{"title3":"Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission."},{"title3":"Hosts and sources of endemic human coronaviruses."},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS."},{"title3":"Origin and evolution of pathogenic coronaviruses."},{"title3":"The European Virus Archive goes global: A growing resource for research."},{"title3":"Developing a framework to assess the costeffectiveness of COMPARE - a global platform for the exchange of sequence-based pathogen data."},{"title3":"Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018."},{"title3":"First international external quality assessment of molecular diagnostics for Mers-CoV."},{"title3":"Advancing preparedness for clinical research during infectious disease epidemics."}]},{"title2":"First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020","References":[{"title3":"World Health Organization (WHO). Novel coronavirus China. Disease outbreak news. Geneva: WHO; 2020. [Accessed: 4 Feb 2020]. Available from: https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/ "},{"title3":"European Centre for Disease Prevention and Control (ECDC). Novel coronavirus. Stockholm: ECDC; 2020. [Accessed 12 Feb 2020]. Available from: https://www.ecdc.europa.eu/en/novel-coronavirus-china "},{"title3":"Haut Conseil de la sante publique (HCSP). Definition et classement des cas possibles et confirmes d'infection a MERS-CoV et precautions a mettre en oeuvre lors de la prise en charge de ces patients. [Definition and classification of possible and confirmed cases of MERS-CoV infection and precautions to be taken when caring for these patients]. Paris: HCSP; 2015. Available from: https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=506 "},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"World Health Organization (WHO). Go.Data: Managing complex data in outbreaks. Geneva: WHO. [Accessed: 4 Feb 2020]. Available from: https://www.who.int/godata "},{"title3":"European Centre for Disease Prevention and Control (ECDC). Public health management of persons having had contact with novel coronavirus cases in the European Union. Stockholm: ECDC; 2020. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/Public-health-management-contact-novel-coronavirus-cases-EU_0.pdf "},{"title3":"World Health Organization (WHO). The First Few X (FFX) Cases and contact investigation protocol for 2019-novel coronavirus (2019-nCoV) infection. Geneva: WHO; 2020. Available from: https://www.who.int/publications-detail/the-first-few-x-(ffx)-cases-and-contact-investigation-protocol-for-2019-novel-coronavirus-(2019-ncov)-infection "},{"title3":"European Centre for Disease Prevention and Control (ECDC). Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA). Stockholm: ECDC; 2020. Available from: https://www.ecdc.europa.eu/en/publications-data/risk-assessment-guidelines-infectious-diseases-transmitted-aircraft-ragida-middle "},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Liu T, Hu J, Kang M, Lin L, Zhong H, Xiao J, et al. Transmission dynamics of 2019 novel coronavirus (2019-nCoV). bioRxiv. 2020:2020.01.25.919787. "},{"title3":"Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019-nCoV. bioRxiv. 2020:2020.01.23.917351. "},{"title3":"Imai N, Cori A, Dorigatti I, Baguelin M, Donnelly C, Riley S, et al. Report 3: Transmissibility of 2019-nCoV. London: Imperial College London; 2020. Available from: https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news--wuhan-coronavirus/ "},{"title3":"Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. The Lancet; 2020: S0140-6736(20)30260-9. "},{"title3":"European Centre for Disease Prevention and Control (ECDC). Outbreak of acute respiratory syndrome associated with a novel coronavirus, China: first local transmission in the EU/EEA - third update. 30 January 2020. Stockholm: ECDC; 2020. Available from: https://www.ecdc.europa.eu/en/publications-data/risk-assessment-outbreak-acute-respiratory-syndrome-associated-novel-1#no-link "}]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Olfactory threshold and nasal mucosal changes in experimentally induced common cold","References":[]},{"title2":"Identification of viruses in patients with post-viral olfactory dysfunction","References":[]},{"title2":"Prognosis of post-viral olfactory loss: follow-up study for longer than one year","References":[]},{"title2":"The occurrence of diarrhea in COVID-19 patients","References":[{"title3":"WHO. Rolling updates on coronavirus disease (COVID-19). Updated 11 March 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen."},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"2019 novel coronavirus infection and gastrointestinal tract"},{"title3":"Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible?"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically-proven protease inhibitor"},{"title3":"Excessive anxiety in IBD patients is unnecessary for COVID-19"},{"title3":"Anatomy of a new coronavirus pneumonia death corpse system"}]}]}]}